Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome

NCT03088046 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Anovulation
Polycystic Ovary Syndrome
Hyperandrogenism

Interventions

DRUG: Micronized Progesterone

Sponsor

Fundacion Dexeus